How do SGLT-2 inhibitor drugs affect type 2 diabetes patients?

SGLT-2 inhibitors reduce blood sugar by helping kidneys remove glucose through urine, and they have been shown to decrease premature deaths by 24%.

What is the estimated impact of SGLT-2 inhibitors on UK deaths?

Researchers suggest that approximately 20,000 deaths could be prevented each year in the UK due to the effectiveness of these new diabetes medications.

What is Nice's stance on SGLT-2 inhibitors for diabetes?

Nice has endorsed SGLT-2 inhibitors as a first-line treatment option for type 2 diabetes, marking a significant change in patient care.

Home / Health / Diabetes Drug Saves Thousands: New Hope for Patients

Diabetes Drug Saves Thousands: New Hope for Patients

10 Feb

•

Summary

New diabetes drug reduces premature deaths by 24%.
Study suggests 20,000 deaths could be prevented annually.
Drugs protect heart and kidneys alongside blood sugar control.

Diabetes Drug Saves Thousands: New Hope for Patients

A new class of SGLT-2 inhibitor medications for type 2 diabetes has demonstrated remarkable effectiveness, potentially preventing approximately 20,000 deaths each year in the UK. Research analyzed data from 60,000 individuals, revealing a 24% decrease in premature mortality over three years compared to other treatments.

These once-daily tablets, including canagliflozin and others, work by aiding the kidneys in glucose removal. This mechanism not only lowers blood sugar but also offers significant protection to the heart and kidneys, according to emerging evidence.

The National Institute for Health and Care Excellence (Nice) has endorsed these SGLT-2 inhibitors as a first-line treatment. This recommendation, supported by UCL and LSHTM experts, signifies a substantial evolution in diabetes management affecting millions across the UK.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.